OQS
GILD icon

Occudo Quantitative Strategies’s Gilead Sciences GILD Stock Holding History

Occudo Quantitative Strategies’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-104,463
Closed -$6.21M – 1222
2022
Q1 		$6.21M Buy
+104,463
New +$6.68M 0.52% 11
2021
Q1 		– Sell
-6,960
Closed -$405K – 820
2020
Q4 		$405K Buy
+6,960
New +$420K 0.13% 313

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Occudo Quantitative Strategies's GILD Position: Q2 2022 in Review

Occudo Quantitative Strategies sold out of Gilead Sciences (GILD) in Q2 2022, closing a stake of 104,463 shares — an estimated $6.21M sold.

Occudo Quantitative Strategies first reported a position in GILD in Q4 2020 and held it in 2 quarters. The position peaked at $6.21M in Q1 2022. 1,603 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

  • Occudo Quantitative Strategies reported no remaining Gilead Sciences position as of Q2 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 104,463 Gilead Sciences shares in Q2 2022, an estimated $6.21M.
  • Occudo Quantitative Strategies first reported a position in Gilead Sciences in Q4 2020 and held it in 2 quarters.
  • Occudo Quantitative Strategies's Gilead Sciences position peaked at $6.21M in Q1 2022.
  • 1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.